Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 3048404 approvals

PeopleBio, Inc.

Official website

KOSDAQ-listed IVD company selling AlzOn and AlzOn+ blood-based oligomeric beta-amyloid tests for Alzheimer's risk assessment.

As of 2026-10-10, PeopleBio, Inc. has 4 Korean MFDS device approvals, 23 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2002 and listed on KOSDAQ in 2020, PeopleBio is an in-vitro diagnostics medical device company. Using its MDS technology to quantitatively measure oligomeric beta-amyloid (OAβ) in blood plasma for Alzheimer's disease risk assessment, it sells the domestic AlzOn test and the export AlzOn+ test. AlzOn received Korean MFDS Class 2 medical device approval in April 2018 and new health technology recognition in December 2021, while AlzOn+ obtained CE marking in November 2020, and the company has signed exclusive 5-10 year supply agreements covering Hungary, Malaysia, Thailand, China, Australia, and the Netherlands.

Products & technology

  • AlzOnblood plasma oligomeric beta-amyloid (OAβ) quantitative test for Alzheimer's risk assessment (domestic)
  • AlzOn+blood plasma oligomeric beta-amyloid (OAβ) quantitative test for Alzheimer's risk assessment (export)

Regulatory approvals

data.go.kr

4 Korean MFDS device approvals · 2017–2023

  • MFDSChemiluminescence assay(CLIA) analyzer2023-02-03
    Product approval · Class 1체외 제신 23-139 호
  • MFDSIVD reagents for general immune test2018-04-23
    Product approval · Class 2체외 제허 18-289 호
  • MFDSIVD reagents for general immune test2017-11-21
    Product approval · Class 2체외 제인 17-4891 호
  • MFDSIVD reagents for general immune testRevoked2017-05-10
    Product approval · Class 2체외 제인 17-4332 호

R&D and key agreements

Source: DART corporate disclosure

OAβ 검사제품 임상시험 · 알츠하이머병 임상진단 보조 · 임상 완료(2017년 품목허가용 임상시험계획서 승인) · Clinical sensitivity and specificity evaluated at Seoul National University Bundang Hospital and Chung-Ang University Hospital

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 13 more publications

Patents

KIPRIS · applicant-matched
Show 38 more patents

AI reads

MAA server logs · IP-verified
50
Times AI engines pulled PeopleBio, Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

50
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

10
live 0
Last 7 days
40
live 0
Last 30 days
50
live 0
All time
  • OpenAIOAI-SearchBot41
  • GoogleGoogleOther4
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 25, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for PeopleBio, Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.2 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

DONG-A ST CO.,LTD2 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

SD BIOSENSOR INC.2 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Amicogen, Inc.1 shared

KOSDAQ-listed industrial biotech producing cephalosporin precursor enzyme CX and antibody-purification Protein A resin.

HUMASIS CO., LTD.1 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

PCL. Inc1 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

TASCOM Co.,Ltd.1 shared

Develops SimplexTAS, a point-of-care clinical chemistry and immunoassay analyzer for IVD testing.

Micro Digital Co., Ltd.1 shared

KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.

GENEMATRIX INC.1 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

QuantaMatrix Incorporated1 shared

Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.

NKGen Biotech Korea Co., Ltd.1 shared

NKGen Biotech Korea licenses out NK cell therapy patents to NKGen Biotech Inc. and provides immune diagnostic and healthcare products.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition